An Australian Patent Opposition and Extension of Term Round-Up from the Patent Office Journal dated 14 June 2012.
Opposition Proceedings
Opposition Lodged
No new oppositions to acceptance have been filed as at 14 June 2012.
Opposition Withdrawn
Opposition to the acceptance of the following applications has been withdrawn as at 14 June 2012:
|
Application No. |
Applicant(s) |
Opponent(s) |
| 2007327557 | EMBERTEC PTY LTD | Emerled Pty Ltd |
| 2009260262 | Colgate-Palmolive Company | Reckitt Benckiser LLC |
| 2009260264 | Colgate-Palmolive Company | Reckitt Benckiser LLC |
Applications Withdrawn
No additional applications have been withdrawn following opposition as at 14 June 2012.
Extensions of Term of Standard Patents
Application accepted
The following application(s) for Extension of Term have been accepted under Section 74:
|
Patent No. |
Patentee(s) |
Goods & New Expiry Date |
| 757772 | Teijin Ltd. | OMNARIS ciclesonide; 21 April 2024 |
| 776587 | Nycomed GmbH | OMNARIS ciclesonide; 20 October 2025 |
Extensions of Term of Standard Patents
The following application(s) for Extension of Term have been granted under Section 76:
|
Patent No. |
Patentee(s) |
Goods & First Reg. Approval |
| 2004235682 | Amgen Inc. | NEULASTA pegfilgrastim; 26 September 2002 (pursuant to Section 77 expires on 26 September 2017) |